Hematology - A new cell-based gene therapy approach to correct hemophilia A
Can't see this email? View it online
   
  Hematology  
  The latest hematology news from News Medical  
 

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemiaProviding Personalized Care for Bleeding Disorders

An interview with Dr. Carmen Escuriola-Ettingshausen MD, Hämophilie-Zentrum Rhein Main, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders such as hemophilia and von Willebrand disease.

Read the Interview
 
   A new cell-based gene therapy approach to correct hemophilia AA new cell-based gene therapy approach to correct hemophilia A
 
In a new study from the Wake Forest Institute for Regenerative Medicine (WFIRM) researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A.
 
   Combination regimen improves overall survival in acute myeloid leukemia patientsCombination regimen improves overall survival in acute myeloid leukemia patients
 
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
 
 Researchers identify new way to treat chronic myelogenous leukemia
 
Researchers identify new way to treat chronic myelogenous leukemiaScientists have detected a second path to treat chronic myelogenous leukemia, which is known to affect older adults, despite its resistance to drugs.
 
 
 Restrictive blood transfusion strategy has no negative impact on anemic heart attack patients
 
Restrictive blood transfusion strategy has no negative impact on anemic heart attack patientsRestricting blood transfusion in anemic heart attack patients to those with very low hemoglobin levels saves blood with no negative impact on clinical outcomes.
 
 
 ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia
 
ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemiaToday, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.